Talaporfin

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Talaporfin
Talaporfin.png
Systematic (IUPAC) name
N-{[(2S,3S)-7-carboxy-3-(2-carboxyethyl)-12-ethyl-2,8,13,18-tetramethyl-17-vinyl-2,3-dihydroporphyrin-5-yl]acetyl}-L-aspartic acid
Clinical data
AHFS/Drugs.com International Drug Names
Legal status
  • Prescription only
Routes IV
Identifiers
CAS number 110230-98-3 YesY
220201-34-3 (sodium salt)
ATC code None
PubChem CID 5486799
ChemSpider 16737134 N
UNII P4ROX5ELT2 YesY
Chemical data
Formula C38H41N5O9 
Mol. mass 711.76 g/mol
 N (what is this?)  (verify)

Talaporfin (INN, also known as aspartyl chlorin, mono-L-aspartyl chlorine e6, NPe6, or LS11) is a photosensitizer used in photodynamic therapy (PDT).

It absorbs red light at 664 nm normally provided by a laser tuned to this wavelength.[1]

It was approved in Japan (in 2004) for PDT of lung cancer and marketed as Laserphyrin.[2]

It is trademarked as Aptocine by Light Sciences Oncology.[3]

References[edit]

  1. ^ http://journals.lww.com/jto/Fulltext/2006/06000/Photodynamic_Therapy__PDT__for_Lung_Cancers.18.aspx "Photodynamic Therapy (PDT) for Lung Cancers" 2006
  2. ^ http://meeting.ascopubs.org/cgi/content/abstract/24/18_suppl/7229 "Photodynamic therapy using Laserphyrin for centrally located early stage lung cancer" 2006
  3. ^ http://www.lsoncology.com/aptocine